AIM ImmunoTech Inc. ( AIM) - Key Metrics
Stock symbol AIM is outdated, potentially delisted? Maybe it is available on other exchange?
AIM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q4 | $0 | -$0.10 | -$0.07 | -$0.07 |
| 2024Q3 | $0 | -$0.06 | -$0.05 | -$0.06 |
| 2024Q2 | $0 | -$0.03 | -$0.06 | -$0.06 |
| 2024Q1 | $0 | -$0.12 | -$0.10 | -$0.10 |
| 2023Q4 | $0 | -$0.26 | -$0.20 | -$0.20 |
AIM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q4 | ? | -0.47 |
| 2024Q3 | ? | -1.05 |
| 2024Q2 | ? | -2.69 |
| 2024Q1 | ? | -1.04 |
| 2023Q4 | ? | -0.43 |
AIM
Price: $0.09
52 week price:
Earnings Per Share: -0.31 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 36383
Market Capitalization: 6.5 million